(CARM) Carmila - Ratings and Ratios
Shopping, Centers, Property, Leasing
Description: CARM Carmila
Carmila SA (CARM) is a French real estate operating company with a market capitalization of approximately €2.47 billion. The companys stock is characterized by a beta of 1.538, indicating a relatively high volatility compared to the overall market.
The stocks current price is €18.04, with a 52-week range of €14.59 to €18.66, suggesting a significant upside potential. The companys price-to-earnings ratio is 7.07, which is relatively low, indicating potential undervaluation. Additionally, the forward P/E ratio is 9.80, suggesting expected earnings growth.
With a return on equity (RoE) of 12.22%, Carmila SA demonstrates a decent ability to generate profits from shareholder equity. To further evaluate the companys performance, key drivers such as rental income growth, occupancy rates, and debt-to-equity ratio should be monitored. Key performance indicators (KPIs) to watch include funds from operations (FFO) per share, net operating income (NOI) margin, and the companys ability to maintain a stable dividend payout.
The real estate operating sector is influenced by macroeconomic factors such as interest rates, GDP growth, and demographic trends. As a French company, Carmila SA is exposed to the European real estate market, which is subject to fluctuations in local economic conditions. The companys financial health and ability to adapt to changing market conditions will be crucial in determining its future stock performance.
To make an informed investment decision, it is essential to analyze Carmila SAs financial statements, managements track record, and industry trends. A thorough examination of the companys leverage, liquidity, and cash flow generation capabilities will provide insights into its ability to navigate potential market downturns and capitalize on growth opportunities.
CARM Stock Overview
| Market Cap in USD | 2,793m |
| Sub-Industry | Real Estate Operating Companies |
| IPO / Inception |
CARM Stock Ratings
| Growth Rating | 75.6% |
| Fundamental | 75.9% |
| Dividend Rating | 80.1% |
| Return 12m vs S&P 500 | -11.4% |
| Analyst Rating | - |
CARM Dividends
| Dividend Yield 12m | 7.37% |
| Yield on Cost 5y | 19.20% |
| Annual Growth 5y | 3.71% |
| Payout Consistency | 83.6% |
| Payout Ratio | 50.4% |
CARM Growth Ratios
| Growth Correlation 3m | 49.6% |
| Growth Correlation 12m | 58.5% |
| Growth Correlation 5y | 96% |
| CAGR 5y | 17.31% |
| CAGR/Max DD 3y | 0.96 |
| CAGR/Mean DD 3y | 3.10 |
| Sharpe Ratio 12m | 0.59 |
| Alpha | -12.40 |
| Beta | 0.828 |
| Volatility | 21.58% |
| Current Volume | 67.9k |
| Average Volume 20d | 87.3k |
| Stop Loss | 16.7 (-3.2%) |
| Signal | 0.09 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (404.9m TTM) > 0 and > 6% of Revenue (6% = 63.2m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 1.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -10.85% (prev 50.42%; Δ -61.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 494.6m > Net Income 404.9m (YES >=105%, WARN >=100%) |
| Net Debt (2.60b) to EBITDA (596.4m) ratio: 4.36 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (140.7m) change vs 12m ago -2.02% (target <= -2.0% for YES) |
| Gross Margin 73.78% (prev 75.56%; Δ -1.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 15.66% (prev 7.23%; Δ 8.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.81 (EBITDA TTM 596.4m / Interest Expense TTM 102.1m) >= 6 (WARN >= 3) |
Altman Z'' 1.68
| (A) -0.02 = (Total Current Assets 320.0m - Total Current Liabilities 434.3m) / Total Assets 6.73b |
| (B) 0.18 = Retained Earnings (Balance) 1.18b / Total Assets 6.73b |
| (C) 0.09 = EBIT TTM 592.6m / Avg Total Assets 6.73b |
| (D) 0.60 = Book Value of Equity 2.03b / Total Liabilities 3.38b |
| Total Rating: 1.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.87
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 6.25% = 3.13 |
| 3. FCF Margin 29.38% = 7.35 |
| 4. Debt/Equity 0.77 = 2.21 |
| 5. Debt/Ebitda 4.32 = -2.50 |
| 6. ROIC - WACC 4.94% = 6.18 |
| 7. RoE 12.22% = 1.02 |
| 8. Rev. Trend 80.18% = 4.01 |
| 9. Rev. CAGR 18.95% = 2.37 |
| 10. EPS Trend 64.77% = 1.62 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of CARM shares?
Over the past week, the price has changed by +2.01%, over one month by -4.54%, over three months by +1.65% and over the past year by +5.46%.
Is Carmila a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CARM is around 19.53 EUR . This means that CARM is currently undervalued and has a potential upside of +13.15% (Margin of Safety).
Is CARM a buy, sell or hold?
What are the forecasts/targets for the CARM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.7 | 19.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 21 | 21.7% |
Last update: 2025-09-14 02:05
CARM Fundamental Data Overview
Market Cap EUR = 2.39b (2.39b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 14.0m EUR (last quarter)
P/E Trailing = 6.8468
P/E Forward = 8.7642
P/S = 4.1858
P/B = 0.7099
Beta = 1.568
Revenue TTM = 1.05b EUR
EBIT TTM = 592.6m EUR
EBITDA TTM = 596.4m EUR
Long Term Debt = 2.58b EUR (from longTermDebt, last quarter)
Short Term Debt = 94.0k EUR (from shortTermDebt, last quarter)
Debt = 2.58b EUR (Calculated: Short Term 94.0k + Long Term 2.58b)
Net Debt = 2.60b EUR (from netDebt column, last fiscal year)
Enterprise Value = 4.95b EUR (2.39b + Debt 2.58b - CCE 14.0m)
Interest Coverage Ratio = 5.81 (Ebit TTM 592.6m / Interest Expense TTM 102.1m)
FCF Yield = 6.25% (FCF TTM 309.6m / Enterprise Value 4.95b)
FCF Margin = 29.38% (FCF TTM 309.6m / Revenue TTM 1.05b)
Net Margin = 38.42% (Net Income TTM 404.9m / Revenue TTM 1.05b)
Gross Margin = 73.78% ((Revenue TTM 1.05b - Cost of Revenue TTM 276.3m) / Revenue TTM)
Tobins Q-Ratio = 2.44 (Enterprise Value 4.95b / Book Value Of Equity 2.03b)
Interest Expense / Debt = 0.37% (Interest Expense 9.47m / Debt 2.58b)
Taxrate = 0.51% (1.61m / 315.8m)
NOPAT = 589.6m (EBIT 592.6m * (1 - 0.51%))
Current Ratio = 0.74 (Total Current Assets 320.0m / Total Current Liabilities 434.3m)
Debt / Equity = 0.77 (Debt 2.58b / last Quarter total Stockholder Equity 3.35b)
Debt / EBITDA = 4.32 (Net Debt 2.60b / EBITDA 596.4m)
Debt / FCF = 8.33 (Debt 2.58b / FCF TTM 309.6m)
Total Stockholder Equity = 3.31b (last 4 quarters mean)
RoA = 6.02% (Net Income 404.9m, Total Assets 6.73b )
RoE = 12.22% (Net Income TTM 404.9m / Total Stockholder Equity 3.31b)
RoCE = 10.06% (Ebit 592.6m / (Equity 3.31b + L.T.Debt 2.58b))
RoIC = 9.49% (NOPAT 589.6m / Invested Capital 6.21b)
WACC = 4.55% (E(2.39b)/V(4.96b) * Re(9.07%)) + (D(2.58b)/V(4.96b) * Rd(0.37%) * (1-Tc(0.01)))
Shares Correlation 3-Years: -9.09 | Cagr: 0.26%
Discount Rate = 9.07% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 65.95% ; FCFE base≈270.1m ; Y1≈177.4m ; Y5≈81.1m
Fair Price DCF = 9.63 (DCF Value 1.35b / Shares Outstanding 140.4m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 80.18 | Revenue CAGR: 18.95%
Rev Growth-of-Growth: 12.07
EPS Correlation: 64.77 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 9.51